Dorsey Wright & Associates’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,337
Closed -$1.03M 157
2026
Q1
$1.03M Buy
+8,337
New +$1.09M 0.13% 127
2019
Q3
Sell
-7,279
Closed -$2.61M 310
2019
Q2
$2.61M Buy
7,279
+9
+0.1% +$2.84K 0.63% 73
2019
Q1
$2.2M Sell
7,270
-4,887
-40% -$1.43M 0.53% 78
2018
Q4
$3.55M Sell
12,157
-2,431
-17% -$753K 1.06% 41
2018
Q3
$5.21M Buy
+14,588
New +$4.67M 0.95% 51

Other funds holding ILMN

Dorsey Wright & Associates's ILMN Position: Q2 2026 in Review

Dorsey Wright & Associates sold out of Illumina (ILMN) in Q2 2026, closing a stake of 8,337 shares — an estimated $1.03M sold.

Dorsey Wright & Associates first reported a position in ILMN in Q3 2018 and held it in 5 quarters. The position peaked at $5.21M in Q3 2018. 932 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Dorsey Wright & Associates reported no remaining Illumina position as of Q2 2026 after selling out during the quarter.
  • Dorsey Wright & Associates sold 8,337 Illumina shares in Q2 2026, an estimated $1.03M.
  • Dorsey Wright & Associates first reported a position in Illumina in Q3 2018 and held it in 5 quarters.
  • Dorsey Wright & Associates's Illumina position peaked at $5.21M in Q3 2018.
  • 932 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.